Protagenic Therapeutics, Inc.\new — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1c379e7e-b8e0-4889-a5fa-5bd8aa5ca19d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.4M | 2025-04-01 – 2026-03-31 | evidence 0001493152-26-038255 |
| FY 2024 | $-3.6M | 2024-04-01 – 2025-03-31 | evidence 0001493152-26-038255 |
| FY 2023 | $-5.0M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012333 |
| FY 2022 | $-3.6M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010152 |
| FY 2021 | $-4.5M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-009370 |
| FY 2020 | $-2.5M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006756 |
| FY 2019 | $-1.8M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-007286 |
| FY 2018 | $-2.6M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004288 |
| FY 2017 | $-2.3M | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-004567 |
| FY 2016 | $-2.3M | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-006686 |
| FY 2015 | $-1.0M | 2015-01-01 – 2015-12-31 | evidence 0001437749-17-006686 |
| FY 2014 | $-302.5k | 2014-01-01 – 2014-12-31 | evidence 0001437749-16-035178 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Protagenic Therapeutics, Inc.\new — all facts · Revenue · Operating Income